CFL1 and breast cancer: Through complimentary cell‐biological experiments, we find that targeted reduction in plasma membrane PI(4,5)P2 by these enzymes releases plasma membrane‐bound cofilin, enhancing actin remodeling in breast cancer cells and increasing their metastatic migration.